For ongoing obesity management, patients should discuss alternative options with their GP or specialist, which may include other pharmacological agents (such as orlistat), behavioural interventions, or referral for bariatric surgery assessment in appropriate cases
Dose-response improvements in glycaemic control and body weight reduction with HM11260C, a once weekly GLP-1 receptor agonist with liraglutide as reference, in type 2 diabetes.[abstract]
Essas propriedades neuroprotetoras so complementadas pela capacidade dos anlogos de GLP-1 de restaurar a via da insulina nos neurnios e reduzir a fosforilao de protenas associadas neurodegenerao, o que pode ser relevante no combate ao Alzheimer e ao Parkinson
Obesity paradox in recurrent attacks of gout in observational studies: clarification and remedy
Combination of prolonged water fasting and GLP-1 for refractory morbid obesity: Case report
Weight loss with GLP-1 medications often requires months to reach goals, and weight maintenance often requires continued medication use
